Table of Content

Chapter 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

Chapter 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

Chapter 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Market dynamics

3.2.1.Drivers

3.2.1.1.Increase in number of infertility cases globally
3.2.1.2.Alcohol consumption leading to infertility issues
3.2.1.3.Rise in awareness regarding infertility treatment options
3.2.1.4.Growth in prevalence of causative factors

3.2.2.Restraints

3.2.2.1.Impact of COVID-19 on the surrogacy market
3.2.2.2.Stringent regulations pertaining commercial surrogacy

3.2.3.Opportunity

3.2.3.1.Rise in fertility tourism

3.3.COVID-19 impact on the market

Chapter 4:SURROGACY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by type
4.1.2.Market size and forecast, by type

4.2.Gestational Surrogacy

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Traditional Surrogacy

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by region

Chapter 5:SURROGACY MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast (Value)
5.1.2.Market size and forecast (volume)

5.2.IVF with ICSI

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region

5.3.IVF without ICSI

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region

5.4.Intrauterine Insemination

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region

Chapter 6:SURROGACY MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by technology

6.2.3.1.U.S. market size and forecast, by type
6.2.3.2.U.S. market size and forecast, by technology
6.2.3.3.Canada market size and forecast, by type
6.2.3.4.Canada market size and forecast, by technology
6.2.3.5.Mexico market size and forecast, by type
6.2.3.6.Mexico market size and forecast, by technology

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by technology

6.3.3.1.UK market size and forecast, by type
6.3.3.2.UK market size and forecast, by technology
6.3.3.3.Rest of Europe market size and forecast, by type
6.3.3.4.Rest of Europe market size and forecast, by technology

6.4.Asia-pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by technology

6.4.3.1.India market size and forecast, by type
6.4.3.2.India market size and forecast, by technology
6.4.3.3.Australia market size and forecast, by type
6.4.3.4.Australia market size and forecast, by technology
6.4.3.5.Rest of Asia-Pacific market size and forecast, by type
6.4.3.6.Rest of Asia-Pacific market size and forecast, by technology

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by technology

6.5.3.1.Brazil market size and forecast, by type
6.5.3.2.Brazil market size and forecast, by technology
6.5.3.3.South Africa market size and forecast, by type
6.5.3.4.South Africa market size and forecast, by technology
6.5.3.5.Rest of LAMEA market size and forecast, by type
6.5.3.6.Rest of LAMEA market size and forecast, by technology

Chapter 7:COMPANY PROFILES

7.1.NEW HOPE FERTILITY CLINIC

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments

7.2.IVI RMA GLOBAL

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments

7.3.HOUSTON FERTILITY CENTER

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments

7.4.CLINIC SCANFERT

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments

7.5.BOURN HALL FERTILITY CLINIC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments

7.6.NOVA IVI FERTILITY

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments

7.7.OVATION FERTILITY

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments

7.8.EXTRAORDINARY CONCEPTIONS

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments

7.9.CARE FERTILITY GROUP

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments

7.10.GROWING GENERATIONS LLC

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments



List of Figures



FIGURE 01.SURROGACY MARKET: MARKET SEGMENTATION
FIGURE 02.MARKET DYNAMICS


List of Tables



TABLE 01.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 02.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 03.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 04.SURROGACY MARKET FOR GESTATIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 05.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 ($MILLION)
TABLE 06.SURROGACY MARKET FOR TRADITIONAL SURROGACY, BY REGION, 2016–2025 (NO. OF CYCLES)
TABLE 07.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 08.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 09.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 10.SURROGACY MARKET FOR IVF WITH ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 11.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 ($MILLION)
TABLE 12.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 13.SURROGACY MARKET FOR IUI, BY REGION, 2015–2025 ($MILLION)
TABLE 14.SURROGACY MARKET FOR IVF WITHOUT ICSI, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 15.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 ($MILLION)
TABLE 16.GLOBAL SURROGACY MARKET, BY REGION, 2015–2025 (NO. OF CYCLES)
TABLE 17.NORTH AMERICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 18.GLOBAL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 19.NORTH AMERICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 20.GLOBAL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 21.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 22.U.S. SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 23.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 24.U.S. SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 25.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 26.CANADA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 27.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 28.CANADA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 29.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 30.MEXICO SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 31.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 32.MEXICO SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 33.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 34.EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 35.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 36.EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 37.UK SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 38.UK SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 39.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 40.UK SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 41.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 42.REST OF EUROPE SURROGACY MARKET, BY TYPE, 2015–2025 (NO.OF CYCLES)
TABLE 43.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 44.REST OF EUROPE SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 45.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 46.ASIA PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 47.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 48.ASIA PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 49.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 50.INDIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 51.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 52.INDIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 53.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 54.AUSTRALIA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 55.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 56.AUSTRALIA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 57.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 58.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 59.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 60.REST OF ASIA-PACIFIC SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 61.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 62.LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 63.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 64.LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 65.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 66.BRAZIL SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 67.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 68.BRAZIL SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 69.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 70.SOUTH AFRICA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 71.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 72.SOUTH AFRICA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 73.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 ($MILLION)
TABLE 74.REST OF LAMEA SURROGACY MARKET, BY TYPE, 2015–2025 (NO. OF CYCLES)
TABLE 75.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 ($MILLION)
TABLE 76.REST OF LAMEA SURROGACY MARKET, BY TECHNOLOGY, 2015–2025 (NO. OF CYCLES)
TABLE 77.NHFC: COMPANY SNAPSHOT
TABLE 78.NHFC: PRODUCT SEGMENTS
TABLE 79.RMA: COMPANY SNAPSHOT
TABLE 80.RMA: SERVICE SEGMENTS
TABLE 81.HOUSTON FERTILITY CENTER: COMPANY SNAPSHOT
TABLE 82.HOUSTON FERTILITY CENTER: OPERATING SEGMENTS
TABLE 83.CLINIC SCANFERT: COMPANY SNAPSHOT
TABLE 84.CLINIC SCANFERT: OPERATING SEGMENTS
TABLE 85.BOURN HALL FERTILITY CLINIC: COMPANY SNAPSHOT
TABLE 86.BOURN HALL FERTILITY CLINIC: PRODUCT SEGMENTS
TABLE 87.NOVA IVI FERTILITY: COMPANY SNAPSHOT
TABLE 88.NOVA IVI FERTILITY: OPERATING SEGMENTS
TABLE 89.OVATION: COMPANY SNAPSHOT
TABLE 90.OVATION: PRODUCT SEGMENTS
TABLE 91.EXTRAORDINARY CONCEPTIONS: COMPANY SNAPSHOT
TABLE 92.EXTRAORDINARY CONCEPTIONS: PRODUCT SEGMENTS
TABLE 93.CARE FERTILITY GROUP: COMPANY SNAPSHOT
TABLE 94.CARE FERTILITY GROUP: OPERATING SEGMENTS
TABLE 95.GROWING GENERATIONS LLC: COMPANY SNAPSHOT
TABLE 96.GROWING GENERATIONS LLC: SERVICES